WHO ICTRP trial

Evaluation of Clinical Effectiveness of High-dose Intravenous…

JPRN-UMIN000000568 · Japan Primary Registries Network (JPRN)

Key facts

Trial ID JPRN-UMIN000000568
Public title Evaluation of Clinical Effectiveness of High-dose Intravenous Immunoglobulin(HD-IVIg) Therapy in Pneumonia with Avian Influenza and Other Influenza
Scientific title Evaluation of Clinical Effectiveness of High-dose Intravenous Immunoglobulin(HD-IVIg) Therapy in Pneumonia with Avian Influenza and Other Influenza - High-dose intravenous immunoglobulin(HD-IVIg) therapy in Pneumonia with severe Avian Influenza and other severe Influenza
Primary sponsor Japan: International Medical Center of Japan Vietnam: National Institute for Infectious and Tropical Diseases, Bach Mai hospital, National Hospital of Pediatrics and other hospitals in Vietnam.
Registry Japan Primary Registries Network (JPRN)
Study type Interventional
Phase Not selected
Countries Japan,Asia(except Japan)
Conditions Severe avian influenza and other severe influenza pneumonia
Interventions High dose immunoglobulin 2g/kg/BW/day in addition to the basic therapy
Registration date Dec 29, 2006
Target size 15
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations